Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety
Objective To report the results of a survey exploring the experience of patients with SLE facing hydroxychloroquine (HCQ) shortage that occurred during the early phases of the COVID-19 pandemic.Methods A survey was designed by Lupus Europe’s patient advisory network and distributed through its socia...
Saved in:
| Main Authors: | Alain Cornet, Chiara Tani, Marta Mosca, Jeanette Andersen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-04-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/8/1/e000496.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHLOROQUINE AND HYDROXYCHLOROQUINE ARE AVAILABLE TREATMENT OPTIONS TO FIGHT WITH COVID-19
by: Shadia S. Alhamd, et al.
Published: (2020-11-01) -
Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
by: Adam Jan Ząbek, et al.
Published: (2025-04-01) -
Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
by: Abdalla Elhwuegi
Published: (2020-01-01) -
Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
by: Xiaoxuan Sun, et al.
Published: (2020-01-01) -
On meta-analytic models and the effect of hydroxychloroquine use in COVID-19
by: Diego Pasquier
Published: (2025-07-01)